1. Home
  2. SOPH vs JRI Comparison

SOPH vs JRI Comparison

Compare SOPH & JRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SOPH

SOPHiA GENETICS SA

HOLD

Current Price

$5.30

Market Cap

367.7M

Sector

Health Care

ML Signal

HOLD

Logo Nuveen Real Asset Income and Growth Fund of Beneficial Interest

JRI

Nuveen Real Asset Income and Growth Fund of Beneficial Interest

HOLD

Current Price

$12.97

Market Cap

357.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOPH
JRI
Founded
2011
2012
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
367.7M
357.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SOPH
JRI
Price
$5.30
$12.97
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$7.50
N/A
AVG Volume (30 Days)
86.1K
125.9K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
9.38%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.09
N/A
Revenue Next Year
$19.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.59
$11.67
52 Week High
$5.70
$14.37

Technical Indicators

Market Signals
Indicator
SOPH
JRI
Relative Strength Index (RSI) 59.99 56.49
Support Level $4.55 $12.78
Resistance Level $5.30 $13.12
Average True Range (ATR) 0.28 0.16
MACD 0.01 -0.01
Stochastic Oscillator 64.85 53.68

Price Performance

Historical Comparison
SOPH
JRI

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

About JRI Nuveen Real Asset Income and Growth Fund of Beneficial Interest

Nuveen Real Asset Income and Growth Fund is a closed-end fund. Its objective is to provide a high level of current income and long-term capital appreciation. The fund invests a majority of its managed assets in equity and debt securities issued by real asset related companies located anywhere in the world. Its plan involves investments in five security types, infrastructure common stock, REIT preferred stock and debt securities. Real asset-related companies include those engaged in owning, operating, or developing infrastructure projects, facilities, and services, as well as REITs.

Share on Social Networks: